Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sharp Shalini
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   215,117    

Indirect Shares

   104,270      
Direct Value   $4,317,035    

Indirect Value

   $46,244      
Total Shares   319,387      
Total Value   $4,363,279      


Agenus Inc $36,061 Ultragenyx Pharmaceutical Inc $3,780,434 Nuvation Bio Ord Shs Class A $364,700 Neurocrine Biosciences Inc $135,840 Agenus Inc $36,061 Ultragenyx Pharmaceutical Inc $3,780,434 Nuvation Bio Ord Shs Class A $364,700 Neurocrine Biosciences Inc $135,840
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    6    

     Stock price went up :
    0   
    5    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   5.0   
     Percentage Gain/Loss :
     0.0%
 537.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agenus Inc AGEN Director 2013-01-30 81,311 2015-09-28 104,270    Premium*  
            Ultragenyx Pharmaceutical Inc RARE EVP, Finance 2020-10-14 97,812 0    Premium*  
            Nuvation Bio Ord Shs Class A NUVB Director 2021-02-10 35,000 2021-02-10 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2024-01-23 0 2021-03-26 0    Premium*  
            Neurocrine Biosciences Inc NBIX Director 2024-05-17 994 2024-05-17 0    Premium*  
* Premium Members only  

Records found :    130         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-12-18 4 AS $44.82 $179,290 D/D (4,000) 64,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-10-20 4 AS $46.02 $184,080 D/D (4,000) 72,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-06-04 4 S $74.01 $189,762 D/D (2,564) 101,208 0 %
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-01-20 4 AS $51.24 $204,957 D/D (4,000) 60,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-08-18 4 AS $53.97 $215,880 D/D (4,000) 80,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-02-18 4 AS $53.93 $215,935 D/D (4,000) 56,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2014-09-18 4 AS $56.00 $224,000 D/D (4,000) 76,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-03-18 4 AS $61.45 $245,800 D/D (4,000) 52,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-04-20 4 AS $61.14 $248,910 D/D (4,000) 48,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-05-18 4 AS $79.43 $317,720 D/D (4,000) 45,255 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-06-18 4 AS $95.95 $384,340 D/D (4,000) 45,655 0 -
MRTX Mirati Therapeutics, Inc. Director   –       •      –    2023-12-29 4 A $58.75 $399,970 D/D 6,808 16,222 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-05-19 4 OE $48.43 $431,710 D/D 7,128 104,851 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-06-03 4 OE $48.43 $495,633 D/D 10,234 111,442 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2015-07-20 4 AS $130.99 $508,532 D/D (3,854) 41,801 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-05-19 4 S $73.32 $522,625 D/D (7,128) 101,556 0 %
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-06-07 4 AS $80.07 $536,456 D/D (6,700) 53,478 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-09-25 4 AS $90.07 $603,469 D/D (6,700) 50,128 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-08-17 4 OE $48.43 $698,524 D/D 11,357 101,856 0 -
RARE Ultragenyx Pharmaceutical... CFO & Senior Vice President   •       –      –    2016-10-19 4 AS $60.98 $736,820 D/D (12,000) 45,387 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2020-06-03 4 S $74.23 $759,670 D/D (10,234) 101,208 0 %
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-05-30 4 AS $70.17 $912,171 D/D (13,000) 57,174 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2017-02-27 4 AS $80.14 $961,680 D/D (12,000) 51,887 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-18 4 AS $70.00 $1,036,000 D/D (14,800) 66,357 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-18 4/A AS $70.00 $1,036,000 D/D (14,800) 66,326 0 -
  130  Records found
  1   2   3   4   5  6      
  Page 5 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us